GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 32.964
AS - Asia 12.343
EU - Europa 10.470
SA - Sud America 1.667
Continente sconosciuto - Info sul continente non disponibili 355
AF - Africa 322
OC - Oceania 45
Totale 58.166
Nazione #
US - Stati Uniti d'America 32.174
SG - Singapore 3.861
GB - Regno Unito 3.566
CN - Cina 3.331
IT - Italia 2.366
HK - Hong Kong 1.452
BR - Brasile 1.290
VN - Vietnam 1.169
SE - Svezia 824
DE - Germania 793
UA - Ucraina 596
FI - Finlandia 571
BD - Bangladesh 552
TR - Turchia 464
RU - Federazione Russa 439
CA - Canada 365
FR - Francia 363
KR - Corea 330
IN - India 255
BG - Bulgaria 224
MX - Messico 143
ID - Indonesia 131
AR - Argentina 119
ES - Italia 117
NL - Olanda 113
IQ - Iraq 105
PK - Pakistan 100
PL - Polonia 98
JP - Giappone 89
IE - Irlanda 80
ZA - Sudafrica 80
AE - Emirati Arabi Uniti 57
EG - Egitto 56
EC - Ecuador 54
CO - Colombia 47
IR - Iran 47
PH - Filippine 47
MA - Marocco 46
AU - Australia 41
TH - Thailandia 40
VE - Venezuela 40
CR - Costa Rica 39
LT - Lituania 39
MY - Malesia 38
SA - Arabia Saudita 38
CL - Cile 37
BE - Belgio 34
IL - Israele 33
JM - Giamaica 33
PE - Perù 32
TT - Trinidad e Tobago 31
HN - Honduras 30
SV - El Salvador 29
CH - Svizzera 28
KE - Kenya 27
UZ - Uzbekistan 27
DZ - Algeria 24
GT - Guatemala 23
RO - Romania 23
TN - Tunisia 23
PR - Porto Rico 22
AT - Austria 21
AZ - Azerbaigian 20
CZ - Repubblica Ceca 20
EE - Estonia 20
UY - Uruguay 20
JO - Giordania 18
PT - Portogallo 18
PY - Paraguay 18
HU - Ungheria 17
NP - Nepal 17
GR - Grecia 16
KG - Kirghizistan 15
NI - Nicaragua 15
DK - Danimarca 14
ET - Etiopia 13
KZ - Kazakistan 13
PA - Panama 13
CW - ???statistics.table.value.countryCode.CW??? 12
AL - Albania 11
TW - Taiwan 11
BH - Bahrain 10
GP - Guadalupe 10
OM - Oman 10
SC - Seychelles 10
BO - Bolivia 9
SN - Senegal 9
GH - Ghana 8
LB - Libano 8
NG - Nigeria 8
RS - Serbia 8
BS - Bahamas 7
NO - Norvegia 7
PS - Palestinian Territory 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
MK - Macedonia 6
SM - San Marino 6
BY - Bielorussia 5
KH - Cambogia 5
Totale 57.713
Città #
Ashburn 4.261
Fairfield 2.484
Southend 2.476
Singapore 2.264
Santa Clara 2.255
Woodbridge 1.621
Hong Kong 1.426
Houston 1.287
Jacksonville 1.163
Hefei 1.107
Chandler 1.040
San Jose 1.027
Seattle 944
Council Bluffs 901
Wilmington 850
Ann Arbor 772
Cambridge 751
Dearborn 656
Beijing 612
Los Angeles 599
London 596
Nyköping 500
Chicago 456
Ho Chi Minh City 375
The Dalles 365
Helsinki 344
Modena 340
Seoul 314
Hanoi 281
Milan 272
Buffalo 257
New York 252
Princeton 243
San Diego 242
Dallas 223
Sofia 217
Eugene 187
Lauterbourg 183
Columbus 172
São Paulo 166
Salt Lake City 164
Izmir 163
Shanghai 114
Munich 112
Rome 111
Moscow 110
Atlanta 108
Orem 98
Phoenix 97
Des Moines 95
Austin 93
Toronto 90
San Francisco 89
Bologna 81
Boardman 79
Frankfurt am Main 76
Guangzhou 75
Elk Grove Village 73
North Bergen 72
Dublin 71
Tampa 70
Bremen 67
Denver 67
Tokyo 66
Redwood City 65
Montreal 64
Jakarta 59
Brooklyn 58
Philadelphia 58
Washington 58
Naples 57
Haiphong 52
Miami 52
Warsaw 52
Kent 50
Da Nang 46
Mexico City 44
Detroit 43
Norwalk 43
Miano 41
Rio de Janeiro 41
Istanbul 40
Turku 39
Boston 38
Honolulu 38
Lancaster 38
Baghdad 37
Falls Church 37
Charlotte 35
Florence 34
Saint Augustine 34
Sterling 33
Cagliari 32
Chennai 32
Turin 32
Johannesburg 30
San José 30
Amsterdam 29
Dhaka 29
Parma 29
Totale 38.251
Nome #
Combined myo-inositol and Banaba (1% Corosolic Acid) improve HOMA-IR and hepatic insulin extraction index in overweight and obese postmenopausal women 737
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 686
Inositol as putative integrative treatment for PCOS 637
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 572
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 484
Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol 477
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 441
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 439
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 433
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 422
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 406
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 396
Alla scoperta dei minerali dell'Isola d'Elba: itinerari e note per la ricerca sulle pegmatiti del Monte Capanne 393
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 383
Neuroendocrinological Aspects of a Tailored Hormonal Contraception 380
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 375
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 366
Diagnostic and therapeutic approach to hypothalamic amenorrhea 360
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 357
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 354
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 351
Inositol and human reproduction. From cellular metabolism to clinical use 349
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 349
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 346
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 343
Use of metformin in the treatment of polycystic ovary syndrome 340
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 340
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 335
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 335
Allopregnanolone concentrations and premenstrual syndrome 335
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 332
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 328
Life events impact in patients with secondary amenorrhoea. 326
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 323
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 322
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 322
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 322
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 319
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 318
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 317
The relevance of inositols treatment for PCOS before and during ART 315
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 313
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 311
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 305
Advances in neurosteroids: Role in clinical practice 300
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 300
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 297
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 296
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 296
Subclinical Atherosclerosis at Peripheral Arteries in Obese Individuals. 296
Obesità e benessere: i rischi per la salute della donna obesa 295
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 293
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 290
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 289
Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients 288
The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications 287
Functional Hypothalamic Amenorrhea as Stress Induced Defensive System 287
Neuroendocrine mechanisms of mood disorders during menopause transition: A narrative review and future perspectives 283
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 278
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 277
Adrenal function under long-term raloxifene administration 276
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both 276
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 275
Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome. A randomized study. 274
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 274
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 273
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies 273
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 272
Episodic secretion of activin A in pregnant women 270
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 270
Metabolismo osseo nelle amenorreaa ipotalamiche da basso peso: il ruolo del trattamento con estroprogestinici 264
Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans 263
Corticotropin-releasing factor-binding protein: Origins and possible functions 263
Female precocious puberty, obesity and polycystic-like ovaries 262
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 261
Prolactin as a neuroendocrine clue in sexual function of women across the reproductive life cycle: an expert point of view 260
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 259
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 258
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 258
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 256
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 256
DHEA as a putative replacement therapy in the elderly 256
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 255
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 255
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 254
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 253
Effects of red clover extracts on breast cancer cell migration and invasion 252
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 251
Aging modifies the hormonal responses in women. 251
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 250
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 250
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 250
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 250
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 248
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 248
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 245
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome 244
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 242
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 241
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 240
Totale 31.974
Categoria #
all - tutte 225.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 225.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.143 0 0 0 0 63 116 277 198 345 211 533 400
2022/20233.137 348 269 172 271 391 517 52 285 422 45 150 215
2023/20242.303 92 145 141 152 551 197 242 315 36 72 145 215
2024/20257.938 334 105 80 608 1.507 1.010 355 487 1.067 720 763 902
2025/202616.663 1.044 714 1.610 1.644 2.192 1.300 1.906 897 1.678 1.562 1.127 989
2026/20279.254 1.456 2.033 1.996 3.082 687 0 0 0 0 0 0 0
Totale 58.166